Ifm Investors Pty LTD Biogen Inc. Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Biogen Inc. stock. As of the latest transaction made, Ifm Investors Pty LTD holds 34,013 shares of BIIB stock, worth $4.98 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

34,013

Previous 34,260 0.72%

Holding current value

$4.98 Million

Previous $7.94 Million 16.99%

% of portfolio

0.06%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$189.07 - $236.8 $46,700 - $58,489	-247 Reduced 0.72%	34,013 $6.59 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $13,717 - $17,043	72 Added 0.21%	34,260 $7.94 Million
Q4 2023 Jan 12, 2024	BUY	$222.59 - $267.94 $247,742 - $298,217	1,113 Added 3.37%	34,188 $8.85 Million
Q3 2023 Oct 26, 2023	BUY	$253.3 - $285.89 $420,984 - $475,149	1,662 Added 5.29%	33,075 $8.5 Million
Q2 2023 Jul 27, 2023	SELL	$275.25 - $318.06 $118,632 - $137,083	-431 Reduced 1.35%	31,413 $8.95 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $206,017 - $234,749	803 Added 2.59%	31,844 $8.85 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $815,633 - $991,012	3,231 Added 11.62%	31,041 $8.6 Million
Q3 2022 Oct 12, 2022	BUY	$194.69 - $268.46 $190,212 - $262,285	977 Added 3.64%	27,810 $7.43 Million
Q2 2022 Jul 15, 2022	BUY	$187.54 - $223.02 $606,879 - $721,692	3,236 Added 13.71%	26,833 $5.47 Million
Q1 2022 Apr 13, 2022	BUY	$193.77 - $244.14 $654,167 - $824,216	3,376 Added 16.7%	23,597 $4.97 Million
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $51,053 - $65,611	-228 Reduced 1.11%	20,221 $4.85 Million
Q3 2021 Oct 13, 2021	SELL	$282.99 - $369.05 $22,639 - $29,524	-80 Reduced 0.39%	20,449 $5.79 Million
Q2 2021 Jul 16, 2021	BUY	$259.0 - $414.71 $838,124 - $1.34 Million	3,236 Added 18.71%	20,529 $7.11 Million
Q1 2021 May 05, 2021	BUY	$242.95 - $284.63 $444,841 - $521,157	1,831 Added 11.84%	17,293 $4.84 Million
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $392,664 - $591,057	1,662 Added 12.04%	15,462 $3.79 Million
Q3 2020 Oct 16, 2020	BUY	$264.77 - $305.71 $210,756 - $243,345	796 Added 6.12%	13,800 $3.92 Million
Q2 2020 Jul 13, 2020	SELL	$258.66 - $342.55 $1.41 Million - $1.86 Million	-5,437 Reduced 29.48%	13,004 $3.48 Million
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $328,534 - $416,750	-1,222 Reduced 6.21%	18,441 $5.83 Million
Q4 2019 Jan 13, 2020	SELL	$220.06 - $304.07 $334,711 - $462,490	-1,521 Reduced 7.18%	19,663 $5.84 Million
Q3 2019 Nov 01, 2019	BUY	$217.44 - $243.88 $1.52 Million - $1.71 Million	7,013 Added 49.49%	21,184 $4.93 Million
Q2 2019 Jul 16, 2019	BUY	$219.29 - $241.72 $175,870 - $193,859	802 Added 6.0%	14,171 $3.31 Million
Q1 2019 Apr 18, 2019	BUY	$216.71 - $338.96 $321,164 - $502,338	1,482 Added 12.47%	13,369 $3.16 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $212,495 - $269,148	763 Added 6.86%	11,887 $3.58 Million
Q3 2018 Oct 22, 2018	BUY	$293.51 - $383.83 $467,267 - $611,057	1,592 Added 16.7%	11,124 $3.93 Million
Q2 2018 Jul 09, 2018	BUY	$257.52 - $306.91 $758,911 - $904,463	2,947 Added 44.75%	9,532 $2.77 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $169,344 - $239,509	651 Added 10.97%	6,585 $1.8 Million
Q4 2017 Jan 29, 2018	SELL	$307.64 - $344.58 $29,533 - $33,079	-96 Reduced 1.59%	5,934 $1.89 Million
Q3 2017 Nov 16, 2017	BUY	$281.15 - $329.69 $22,773 - $26,704	81 Added 1.36%	6,030 $1.89 Million
Q2 2017 Nov 21, 2017	BUY	N/A	5,949 New	5,949 $1.61 Million
Q2 2017 Aug 10, 2017	SELL	N/A	-4,458 Closed	0 $0
Q1 2017 Nov 21, 2017	BUY	N/A	4,458	4,458 $1.22 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Biogen Inc. Transaction History